Absorption, tissue distribution, tissue metabolism and safety of α-mangostin in mangosteen extract using mouse models

Food and Chemical Toxicology

Volumn 66, Issue , 2014, Pages 140-146

  Choi, Young Hee ^a   Han, Seung Yon ^a   Kim, You Jin ^a   Kim, Young Mi ^a   Chin, Young Won ^a  

^a Dongguk University   (South Korea)

Author keywords

Mangostin; Absorption; Mangosteen extract; Mouse; Pharmacokinetics; Safety

Indexed keywords

ALPHA MANGOSTIN; PLANT EXTRACT; PLASMA PROTEIN; UNCLASSIFIED DRUG; MANGOSTIN; XANTHONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG DOSE COMPARISON; DRUG ISOLATION; DRUG PROTEIN BINDING; DRUG SAFETY; GARCINIA MANGOSTANA; INTESTINE; LC 50; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; PHYTOCHEMISTRY; TISSUE DISTRIBUTION; TISSUE METABOLISM; ANIMAL; CHEMISTRY; INSTITUTE FOR CANCER RESEARCH MOUSE; LD 50; METABOLISM;

ANIMALS; BLOOD PROTEINS; GARCINIA MANGOSTANA; LETHAL DOSE 50; MALE; MICE; MICE, INBRED ICR; MODELS, ANIMAL; PLANT EXTRACTS; TISSUE DISTRIBUTION; XANTHONES;

EID: 84896738177     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.01.028     Document Type: Article

References (38)

1. An G., Morris M.E. A physiologically based pharmacokinetic model of mitoxantrone in mice and scale-up to humans: a semi-mechanistic model incorporating DNA and protein binding. AAPS J. 2012, 14:352-364.
2. Balunas M.J., Su B., Brueggemeier R.W., Kinghorn A.D. Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity. J. Nat. Prod. 2008, 71:1161-1166.
3. Bumrungpert A., Kalpravidh R.W., Suksamrarn S., Chaivisuthangkura A., Chitchumroonchokchai C., Failla M.L. Bioaccessibility, biotransformation, and transport of alpha-mangostin from Garcinia mangostana (Mangosteen) using simulated digestion and Caco-2 human intestinal cells. Mol. Nutr. Food Res. 2009, 53:54-61.
4. Chae H.-S., Oh S.-R., Lee H.-K., Joo S.H., Chin Y.-W. Mangosteen xanthones, α- and γ-mangostins, inhibit allergic mediators in bone marrow-derived mast cell. Food Chem. 2012, 134:397-400.
5. Chairungsrilerd N., Furukawa K., Ohta T., Nozoe S., Ohizumi Y. Histaminergic and serotonergic receptor blocking substances from the medical plant Garcinia mangostatna. Planta Med. 1996, 62:471-472.
6. Chin Y.-W., Kinghorn A.D. Structural characterization, biological effects, and synthetic studies on xanthones from mangosteen (Garcinia mangostana), a popular botanical dietary supplement. Mini-Rev. Org. Chem. 2008, 5:355-364.
7. Chitchumroonchokchai C., Riedi K.M., Suksumrarn S., Clinton S.K., Kinghorn A.D., Failla M.L. Xanthoes in mangosteen juice are absorbed and partially conjugated by healthy adults. J. Nutr. 2012, 142:675-680.
8. Chitchumroonchokchai C., Thomas-Ahner J.M., Li J., Riedl K.M., Nontakham J., Suksumrarn S., Clinton S.K., Kinghorn A.D., Failla M.L. Anti-tumorigenicity of dietary alpha-mangostin in an HT-29 colon cell xenograft model and the tissue distribution of xnathones and their phase II metabolites. Mol. Nutr. Food Res. 2013, 57:203-211.
9. Choi Y.H., Kim S.G., Lee M.G. Dose-independent pharmacokinetics of metformin in rats: hepatic and gastrointestinal first-pass effects. J. Pharm. Sci. 2006, 95:2543-2552.
10. Chomnawang M.T., Surassmo S., Wongsariya K., Bunyapraphatsara N. Antibacterial activity of Thai medicinal plants against methicillin-resistant Staphylococcus aureus. Fitoterapia 2009, 80:102-104.
11. Cui J., Hu W., Cai Z., Liu Y., Li S., Tao W., Xiang H. New medical properties of mangostins: analgestic activity and pharmacological characterization of active ingredients from the fruit hull of Garcinia mangostana L. Pharmacol. Biochem. Behav. 2010, 95:166-172.
12. Davies B., Morris T. Physiological parameters in laboratory animals and humans. Pharm. Res. 1993, 10:1093-1095.
13. De Smet P.A., Brouwers J.R. Pharmacokineitc evaluation of herbal remedies: basic introduction, applicability, current status and regulatory needs. Clin. Pharmacokinet. 1997, 32:427-436.
14. Esimone C.O., Nwafor S.V., Okoli C.O., Chah K.F., Uzuegbu D.B., Chibundu C., Eche M.A., Adikwu M.U. In vivo evaluation of interaction between aqueous seed extract of Garcinia kola Heckel and ciprofloxacin hydrochloride. Am. J. Ther. 2002, 9:275-280.
15. Foti R.S., Wahlstrom J.L. The role of dietary supplements in cytochrome P450-mediated drug interactions. Blacpma 2008, 7:66-84.
16. Foti R.S., Pearson J.T., Rock D.A., Wahlstrom J.L., Wienkers L.C. In vitro inhibition of multiple cytochrome P450 isoforms by xanthone derivatives from mangosteen extract. Drug Metab. Dispos. 2009, 37:1848-1855.
17. Gao W.J., Wang X., Ma C.J., Dai R.H., Bi K.S., Chen X.H. Comparative study on pharmacokinetics of senkyunolide I after administration of simple recipe and compound recipe in rats. Zhongguo Zhong Yao Za Zhi 2013, 38:427-431.
18. Gunaratna P.C., Kissinger P.T., Kissinger C.B., Gitzen J.F. An automated blood sampler for simultaneous sampling of systemic blood and brain microdialysates for drug absorption, distribution, metabolism, and elimination studies. J. Pharmacol. Toxicol. Methods 2004, 49:57-64.
19. Han A.R., Kim J.A., Lantvit D.D., Kardono L.B., Riswan S., Chai H., Carcache de Blanco E.J., Farnsworth N.R., Swanson S.M., Kinghorn A.D. Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen). J. Nat. Prod. 2009, 72:2028-2031.
20. Han S.Y., Chin Y.-W., Choi Y.H. A new approach for pharmacokinetic studies of natural products: measurement of isoliquiritigenin levels in mice plasma, urine and feces using modified automated dosing/blood sampling system. Biomed. Chromatogr. 2013, 27:741-749.
21. Han S.Y., Chin Y.-W., Kim D.Y., Choi Y.H. Simultaneous determination of α- and γ-mangostins in mouse plasma by HPLC-MS/MS method: application to a pharmacokinetic study of mangosteen extract in mouse. Chromatographia 2013, 76:643-650.
22. Hussain K., Ismail Z., Sadikun A., Ibrahim P. Bioactive markers based pharmacokientic evaluation of extracts of a traditional medicinal plant, Piper sarmentosum. Evid. Based Complement. Alternat. Med. 2011, 2011:1-7.
23. Jang H.-Y., Kwon O.-K., Oh S.-R., Lee H.-K., Ahn K.-S., Chin Y.-W. Mangosteen xanthones mitigate ovalbumin-induced airway inflammation in a mouse model of asthma. Food Chem. Toxicol. 2012, 50:4042-4050.
24. Lee M.G., Chiou W.L. Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. J. Pharmacokinet. Biopharmaceut. 1983, 11:623-640.
25. Li L., Brunner I., Han A.R., Hamburger M., Kinghorn A.D., Frye R., Butterweck V. Pharmacokinetics of alpha-mangostin in rats after intravenous and oral application. Mol. Nutr. Food Res. 2011, 55(suppl 1):S67-S74.
26. Li L., Han A.R., Kinghorn A.D., Frye R.F., Derendorf H., Butterweck V. Pharmacokinetic properties of pure xanthones in comparison to a mangosteen fruit extract in rats. Planta Med. 2013, 79:646-653.
27. Mitruka B.M., Rawnsley H.M. Clinical Biochemical and Hematological Reference Values in Normal Experimental Animals and Normal Humans 1987, Masson Pub, New York, p. 113. second ed.
28. Nahrstedt A., Butterweck V. Lessons learned from herbal medicinal products: the example of St. John's Wort. J. Nat. Prod. 2010, 73:1015-1021.
29. Peng W.W., Li W., Li J.S., Cui X.B., Zhang Y.X., Yang G.M., Wen H.M., Cai B.C. The effects of Rhizoma Zingiberis on pharmacokinetics of six Aconitum alkaloids in herb couple of Radix Aconiti Lateralis-Rhizoma Zingiberis. J. Ethnopharmacol. 2013, 148(2):579-586.
30. Perrier D., Gibaldi M. General derivation of the equation for time to reach a certain fraction of steady state. J. Pharm. Sci. 1982, 71:474-475.
31. Qiao X., Ye M., Xiang C., Wang Q., Liu C.F., Miao W.J., Guo D.A. Analytical strategy to reveal the in vivo process of multi-component herbal medicine: a pharmacokinetic study of licorice using liquid chromatography coupled with triple quadrupole mass spectrometry. J. Chromatogr. A. 2012, 1258:84-93.
32. Quan G.-H., Oh S.-R., Kim J.-H., Lee H.-K., Kinghorn A.D., Chin Y.-W. Xanthone constituents of the fruits of Garcinia mangostana with anticomplement activity. Phytother. Rese. 2010, 24:1575-1577.
33. Ritchie M.R. Use of herbal supplements and nutritional supplements in the UK: what do we know about their patterns of usage?. Proc. Nutririon Soc. 2007, 66:479-482.
34. Shih Y.W., Chien S.T., Chen P.S., Lee J.H., Wu S.H., Yin L.T. α-Mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expression via αvβ3 integrin/FAK/ERK and NF-κB signaling pathway in human lung adenocarcinoma A549 cells. Cell Biochem. Biophys. 2010, 58:31-44.
35. Skalli S., Zaid A., Soulaymani R. Drug interactions with herbal medicines. Ther. Drug Monit. 2007, 29:679-686.
36. Wilbrandt T. Behrens methods for calculation of LD50. Arzneimittelforschung 1952, 2:501-503.
37. Yesennia S.P., Rocio M.B., Claudia M.G.C., Rebeca L.M., Mariel C.O., Jose P.C., Yolanda I.C. The α-mangostin prevention on cisplatin-induced apoptotic death in LLC-PK1 cells is associated to an inhibition of ROS production and p53 induction. Chem. Biol. Interact. 2010, 188:144-150.
38. Yokozawa T., Liu Z.W. The role of ginsenoside-Rd in cisplatin-induced acute renal failure. Ren. Fail. 2000, 22:115-127.